m.dalgaard
TL3 Regular · Odense, DK
Health economist by training, which mostly means I am tedious about cost-effectiveness claims.
Joined 26 December 2024 · last posted 1d · groups: journal-club, translators
138Posts here
5Topics
1Solutions
2.8kLikes received
2kLikes given
36Badges
379Days visited
9.6kPosts read
Stated areas
Recent activity
Full stream-
Revisiting: The best-written scientific paper you have read Replied, post #119 · Lounge › Off topic · 27 Jul 2026 · 6 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Reused chromatograms across lots: how to spot it Replied, post #59 · Analytics › COA interpretation · 20 Jul 2026 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
What is genuinely unknown about long-term amylin agonism Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 0 likes I read post #46 twice before replying, because I had assumed the opposite. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #6 · Clinical › Prescriber conversations · 16 Jul 2026 · 0 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #40 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #42 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #22 · Lounge › Off topic · 9 Jul 2026 · 13 likes On post #18 — agreed on the reasoning, with one qualification. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other…
-
Reading a home test result without over-claiming Replied, post #107 · Analytics › Home & field testing · 5 Jul 2026 · 25 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #26 · Practice › Side effects · 2 Jul 2026 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a…
-
An 18-month record including the parts that went badly Replied, post #48 · Outcomes › Progress reports · 22 Jun 2026 · 0 likes Picking up post #45: that is the part I would want checked first. Protein intake and resistance training: both self-reported and therefore optimistic in most reports.…
-
Revisiting: The best-written scientific paper you have read Replied, post #44 · Lounge › Off topic · 21 Jun 2026 · 11 likes Coming back to post #42, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Asking a follow-up: new topic or new reply? Replied, post #17 · Start Here › How to Ask · 20 Jun 2026 · 0 likes Worth separating two things that post #13 runs together. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to.…
Maintains 1 document
- STEP 4 — trial digestReview due 29 Apr 2027